ABBV

AbbVie Inc. is a global biopharmaceutical company focused on discovering, developing, and commercializing advanced therapies for serious health conditions. The company operates across multiple therapeutic areas including immunology, oncology, neuroscience, eye care, and aesthetics. AbbVie's flagship immunology product, Humira, has been one of the world's top-selling drugs, treating autoimmune diseases like rheumatoid arthritis, Crohn's disease, and psoriasis. The company has successfully diversified its portfolio with next-generation immunology drugs Rinvoq and Skyrizi, which are experiencing strong growth. AbbVie's oncology portfolio includes blood cancer treatments and solid tumor therapies. The Allergan acquisition in 2020 added Botox and a leading aesthetics franchise. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie is headquartered in North Chicago, Illinois. The company invests heavily in research and development, strategic partnerships, and bolt-on acquisitions to maintain a robust pipeline addressing unmet medical needs and driving sustainable growth.